SCHEMBL623807

SCHEMBL623807

CC(=O)c1cccc(-c2cn3nc(N(C)CC4CCN(C)CC4)sc3n2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR5A2 O00482 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
F2RL3 Q96RI0 3/20 0.39
MAP4K4 O95819 2/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
ABL1 P00519 1/20 0.38
NTRK1 P04629 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
FGFR1 P11362 1/20 0.38
PRKACA P17612 1/20 0.38
KDR P35968 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625257 0.81 FYN (0.47) NR5A2NPC1RAB9ASMN1; SMN2MAP4K4
SCHEMBL623806 0.81 FYN (0.54) PIM1PIM2FYN
SCHEMBL624434 0.77 JAK2 (0.48) ALDH1A1L3MBTL1SMN1; SMN2F2RL3JAK2
SCHEMBL624904 0.77 F2RL3 (0.41) NPC1RAB9ASMN1; SMN2F2RL3JAK2
SCHEMBL625331 0.75 PIM1 (0.45) ALDH1A1L3MBTL1F2RL3JAK2PIM1
SCHEMBL2250766 0.74 FYN (0.53) NPC1RAB9ASMN1; SMN2F2RL3PIM1
SCHEMBL624009 0.73 PIM1 (0.44) F2RL3FGFR1KDRTYRO3PIM1
SCHEMBL1945954 0.70 FYN (0.56) NR5A2PIM1PIM2FYN
SCHEMBL1946233 0.70 FYN (0.56) ALDH1A1LMNANPC1FYNHRH3
SCHEMBL15603196 0.70 FYN (0.66) NPC1RAB9ASMN1; SMN2F2RL3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed